Memantine Grindeks (Memantine Hydrochloride)

Memantine Hydrochloride works as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium influx through the receptor channel, it limits glutamate‑induced excitotoxicity while preserving normal synaptic transmission, which supports neuronal health in Alzheimer’s patients.

The dose of Memantine Grindeks is individualized by the prescribing clinician based on the patient’s condition, renal function and tolerability. The prescriber determines the appropriate starting and maintenance doses according to current clinical guidelines.

Safety data for Memantine during pregnancy and lactation are limited. The potential risks and benefits should be discussed with a healthcare professional, and the drug should only be used if the expected benefit justifies any possible risk to the fetus or infant.

To order Memantine Grindeks, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, whereas many other Alzheimer’s drugs are cholinesterase inhibitors. Memantine offers a different mechanism that may be used alone or in combination with a cholinesterase inhibitor to provide additional cognitive benefit, especially in moderate to severe disease stages.

Memantine Grindeks should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.

Memantine Grindeks is taken orally, usually as a tablet swallowed whole with water. It can be taken with or without food, and the dosing schedule is set by the prescribing physician to match the patient’s therapeutic needs.

Serious risks include the possibility of seizures, severe skin reactions such as Stevens‑Johnson syndrome, hepatotoxicity, suicidal thoughts or behaviors, psychosis, and cardiac arrhythmias. Patients should seek immediate medical attention if any of these events occur.

Memantine Grindeks should be avoided in individuals with known hypersensitivity to memantine or any of its excipients, and it should be used with caution in patients with severe renal impairment or uncontrolled epilepsy. A healthcare professional should evaluate suitability before initiating therapy.